Do Cruz
Adult Health · Suwanee, GANPI 1710387204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 692 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 692 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$3K
- Novartis$2K
- Johnson & Johnson$1K
- AstraZeneca$986
- UCB, Inc.$978
- plus $3K from 27 others
What the payments were for
- Food & beverage$13,19897%
- Education$3983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 156 | $3,078 |
| Amgen(2 entities) | 126 | $2,719 |
| Novartis | 139 | $1,715 |
| Johnson & Johnson(2 entities) | 59 | $1,367 |
| AstraZeneca(2 entities) | 27 | $986 |
| UCB, Inc. | 47 | $978 |
| Pfizer | 34 | $569 |
| Boehringer Ingelheim | 20 | $367 |
| Mallinckrodt Hospital Products Inc. | 11 | $340 |
| GSK | 11 | $204 |
| ANI Pharmaceuticals, Inc. | 7 | $164 |
| Lilly USA, LLC | 8 | $152 |
| Aurinia Pharma U.S., Inc. | 6 | $149 |
| Radius Health, Inc. | 5 | $132 |
| E.r. Squibb & Sons, L.L.C. | 3 | $67 |
| Organon | 4 | $66 |
| Sobi, Inc | 2 | $55 |
| Nestle Healthcare Nutrition Inc. | 3 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Sanofi | 2 | $44 |
| Eisai Inc. | 3 | $42 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Octapharma USA, Inc. | 1 | $25 |
| Gilead | 1 | $21 |
| Vivus LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Sandoz | 1 | $19 |
| Merck | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,597 in reported general payments places this provider in the 95th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $98,389 |
| Diclofenac Sodium | 27 | $3,595 |
| Hydroxychloroquine Sulfate | 104 | $3,539 |
| MethotrexateMethotrexate Sodium | 75 | $1,636 |
| Gabapentin | 82 | $1,035 |
| Leflunomide | 36 | $1,001 |
| Prednisone | 129 | $702 |
| Ibandronate Sodium | 18 | $561 |
| Duloxetine Hcl | 24 | $458 |
| Sulfasalazine | 11 | $368 |
| Pregabalin | 12 | $358 |
| Triamcinolone Acetonide | 15 | $212 |
| Alendronate Sodium | 19 | $180 |
| Methylprednisolone | 28 | $156 |
| Cyclobenzaprine Hcl | 13 | $113 |
Paid to pharmacies, not to this prescriber.
Other adult health in Suwanee
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
- Melissa BaughcumAthens$23K
- Kristine AdamsMarietta$21K
- Jenina LagascaAtlanta$17K
- Jennifer SheldonMacon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.